Cargando…
C-Reactive Protein Apheresis as Anti-inflammatory Therapy in Acute Myocardial Infarction: Results of the CAMI-1 Study
Background: C-reactive protein (CRP) is a well-known marker of inflammation. It is less known that CRP mediates tissue damage in acute myocardial infarction (AMI) thus potentially worsening prognosis. A newly developed specific CRP adsorber allows efficient lowering of CRP levels and may improve sur...
Autores principales: | Ries, Wolfgang, Torzewski, Jan, Heigl, Franz, Pfluecke, Christian, Kelle, Sebastian, Darius, Harald, Ince, Hueseyin, Mitzner, Steffen, Nordbeck, Peter, Butter, Christian, Skarabis, Horst, Sheriff, Ahmed, Garlichs, Christoph D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988098/ https://www.ncbi.nlm.nih.gov/pubmed/33778017 http://dx.doi.org/10.3389/fcvm.2021.591714 |
Ejemplares similares
-
Imaging Predictors of Left Ventricular Functional Recovery after Reperfusion Therapy of ST-Elevation Myocardial Infarction Assessed by Cardiac Magnetic Resonance
por: Virbickiene, Agneta, et al.
Publicado: (2023) -
Sustainability of C-Reactive Protein Apheresis in Acute Myocardial Infarction—Results from a Supplementary Data Analysis of the Exploratory C-Reactive Protein in Acute Myocardial Infarction-1 Study
por: Skarabis, Horst, et al.
Publicado: (2022) -
“First in Man”: Case Report of Selective C-Reactive Protein Apheresis in a Patient with Acute ST Segment Elevation Myocardial Infarction
por: Ries, Wolfgang, et al.
Publicado: (2018) -
Targeting C-Reactive Protein by Selective Apheresis in Humans: Pros and Cons
por: Torzewski, Jan, et al.
Publicado: (2022) -
Successful Treatment of a 39-Year-Old COVID-19 Patient with Respiratory Failure by Selective C-Reactive Protein Apheresis
por: Torzewski, Jan, et al.
Publicado: (2021)